GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rize Oncology Inc (XCNQ:RIZE) » Definitions » Sale Of Business

Rize Oncology (XCNQ:RIZE) Sale Of Business : C$0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Rize Oncology Sale Of Business?

Rize Oncology's sale of business for the three months ended in Sep. 2024 was C$0.00 Mil. It means Rize Oncology gained C$0.00 Mil from selling business. Rize Oncology's sale of business for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Jun. 2024 ), Rize Oncology gained the same money from selling business in Sep. 2024 (C$0.00 Mil).


Rize Oncology Sale Of Business Historical Data

The historical data trend for Rize Oncology's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rize Oncology Sale Of Business Chart

Rize Oncology Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Sale Of Business
- - - -

Rize Oncology Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Rize Oncology Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rize Oncology Sale Of Business Related Terms

Thank you for viewing the detailed overview of Rize Oncology's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Rize Oncology Business Description

Traded in Other Exchanges
N/A
Address
301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, X1X 1X1
Rize Oncology Inc is is a pharmaceutical company. The company is engaged in oncology, particularly soft tissue sarcoma, introduced by the recent exclusive licensing of STS-201, delivering small molecule targeting soft tissue sarcoma and other cancers.
Executives
William James Garner 10% Security Holder, Director

Rize Oncology Headlines

No Headlines